Attached files

file filename
EX-31.1 - EX-31.1 - MERRIMACK PHARMACEUTICALS INCd851670dex311.htm
EX-21.1 - EX-21.1 - MERRIMACK PHARMACEUTICALS INCd851670dex211.htm
EX-10.9 - EX-10.9 - MERRIMACK PHARMACEUTICALS INCd851670dex109.htm
EX-23.1 - EX-23.1 - MERRIMACK PHARMACEUTICALS INCd851670dex231.htm
EX-10.6 - EX-10.6 - MERRIMACK PHARMACEUTICALS INCd851670dex106.htm
EX-31.2 - EX-31.2 - MERRIMACK PHARMACEUTICALS INCd851670dex312.htm
EX-10.33 - EX-10.33 - MERRIMACK PHARMACEUTICALS INCd851670dex1033.htm
EX-10.15 - EX-10.15 - MERRIMACK PHARMACEUTICALS INCd851670dex1015.htm
EX-10.22 - EX-10.22 - MERRIMACK PHARMACEUTICALS INCd851670dex1022.htm
EXCEL - IDEA: XBRL DOCUMENT - MERRIMACK PHARMACEUTICALS INCFinancial_Report.xls
10-K - FORM 10-K - MERRIMACK PHARMACEUTICALS INCd851670d10k.htm
EX-32.1 - EX-32.1 - MERRIMACK PHARMACEUTICALS INCd851670dex321.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Merrimack Pharmaceuticals, Inc. (the “Company”) for the period ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, William A. Sullivan, Chief Financial Officer and Treasurer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that to his knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: February 27, 2015

/s/ William A. Sullivan

William A. Sullivan
Chief Financial Officer and Treasurer
(Principal Financial Officer)